HomeBusinessCongressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drugFILE PHOTO: FILE PHOTO: A sign marks a Biogen facility Estimated read time 1 min read FILE PHOTO: FILE PHOTO: A sign marks a Biogen facility FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S., March 9, 2020. REUTERS/Brian Snyder/File Photo